Institution

Leibniz-Institut für Immuntherapie (LIT)

  • Biotech
Location:
Regensburg, Germany

Description

Leibniz-Institut für Immuntherapie (LIT) develops immune-cell therapies using synthetic and pharmacological reprogramming, with work spanning basic immune research, preclinical immune-cell therapeutic development, and early clinical trials for cancer, autoimmunity, and chronic inflammation.